NCT06622174
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada
Clinical trial condition
Bronchial Neoplasms
Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.
5,268 public trials
1,196 recruiting studies
Bronchial Neoplasms trial results
Not Yet Recruiting
Cancer Patient Remote Monitoring for Timely Communication Study
NCT06623786
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Local Injection and Systemic Therapy in the Treatment of NSCLC.
NCT06618391
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT06620822
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer
NCT06614231
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer
NCT06614621
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC
NCT06613308
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC
NCT06607926
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Xuanwu Hospital, Capital Medical University Beijing, China
Not Yet Recruiting
Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases
NCT06537297
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Hunan Cancer Hospital Changsha, Hunan, China
Not Yet Recruiting
Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic
NCT06497543
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Yongchang Zhang Changsha, Hunan, China